EUVIMEDEUVIMED entdecken
Open Access

Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signaling is involved in phagocytosis activation during THP-1 cell differentiation

Hiroka Murokawa, Karin Egusa, Shusaku Shibutani, Hiroyuki Iwata

Journal of Veterinary Medical Science · 2023

DOI: 10.1292/jvms.22-0504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Medical Science, 2023. Verfasst von Hiroka Murokawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Hygiene, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, MTOR Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) is a serine/threonine kinase that plays a major role in cell metabolism. Although mTORC1 inhibitors are known to exert immunosuppressive effects, their effects on immune cells are not fully understood. In the present study, we examined the involvement of mTORC1 in the differentiation and functions of macrophages using THP-1 cells, which are derived from human monocytic leukemia and differentiate into macrophage-like cells upon treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA). We also examined the effects of two mTOR inhibitors, Torin 1 and rapamycin, on TPA-stimulated THP-1 cells. Although mTORC1 activation was observed upon TPA stimulation, mTOR inhibitors did not affect TPA-induced morphological changes or expression of the general macrophage marker, CD11b. In contrast, phagocytosis and fluid endocytosis were significantly impaired by the mTOR inhibitors. Endocytosis suppression was observed when mTOR inhibitors were added during differentiation, but not before or after differentiation, suggesting that endocytosis suppression altered the direction of differentiation. Furthermore, mTOR inhibitors altered the expression of M1/M2 polarization markers. These results suggest that the immunosuppressive effects of mTOR inhibitors may involve the suppression of macrophage endocytosis caused by abnormal cell differentiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesMTOR InhibitorsHumansAnimalsMechanistic Target of Rapamycin Complex 1THP-1 CellsCell DifferentiationPhagocytosisMammals

Stichwörter der Autor:innen

THP-1macrophagemechanistic/mammalian target of rapamycin (mTOR)mechanistic/mammalian target of rapamycin complex 1 (mTORC1)phagocytosis

Substanzen

Mechanistic Target of Rapamycin Complex 1TOR Serine-Threonine KinasesMTOR Inhibitors

Autor:innen und Institutionen

  • Laboratory of Veterinary Hygiene, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.

Zitieren

APA

Murokawa, H., Egusa, K., Shibutani, S., & Iwata, H. (2023). Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signaling is involved in phagocytosis activation during THP-1 cell differentiation. Journal of Veterinary Medical Science. https://doi.org/10.1292/jvms.22-0504

Vancouver

Murokawa H, Egusa K, Shibutani S, Iwata H. Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signaling is involved in phagocytosis activation during THP-1 cell differentiation. Journal of Veterinary Medical Science. 2023. doi:10.1292/jvms.22-0504

BibTeX
@article{Murokawa2023,
  author = {Murokawa, Hiroka and Egusa, Karin and Shibutani, Shusaku and Iwata, Hiroyuki},
  title = {Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) signaling is involved in phagocytosis activation during THP-1 cell differentiation},
  journal = {Journal of Veterinary Medical Science},
  year = {2023},
  doi = {10.1292/jvms.22-0504}
}
Kostenlos starten →